S2k guideline diagnosis, prevention, and therapy of hand eczema.
Journal
Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG
ISSN: 1610-0387
Titre abrégé: J Dtsch Dermatol Ges
Pays: Germany
ID NLM: 101164708
Informations de publication
Date de publication:
09 2023
09 2023
Historique:
received:
09
05
2023
accepted:
14
06
2023
medline:
14
9
2023
pubmed:
13
9
2023
entrez:
13
9
2023
Statut:
ppublish
Résumé
The consensus-based guideline "Diagnosis, prevention, and treatment of hand eczema (HE)" provides concrete instructions and recommendations for diagnosis, prevention, and therapy of HE based on an evidence- and consensus-based approach. The guideline was created based on the German guideline "Management von Handekzemen" from 2009 and the current guideline of the European Society of Contact Dermatitis (ESCD) "Guidelines for diagnosis, prevention, and treatment of hand eczema" from 2022. The general goal of the guideline is to provide dermatologists and allergologists in practice and clinics with an accepted, evidence-based decision-making tool for selecting and conducting suitable and sufficient therapy for patients with hand eczema. The guideline is based on two Cochrane reviews of therapeutic and preventive interventions for HE. The remaining chapters were mainly developed and consented based on non-systematic literature research by the expert group. The expert group consisted of members of allergological and occupational dermatological professional associations and working groups, a patient representative, and methodologists. The proposals for recommendations and key statements were consented by using a nominal group process during a consensus conference on September 15, 2022. The structured consensus-building process was professionally moderated. This guideline is valid until February 22, 2028.
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1054-1074Informations de copyright
© 2023 The Authors. Journal der Deutschen Dermatologischen Gesellschaft published by John Wiley & Sons Ltd on behalf of Deutsche Dermatologische Gesellschaft.
Références
Thyssen JP, Schuttelaar MLA, Alfonso JH, et al. Guidelines for diagnosis, prevention, and treatment of hand eczema. Contact Dermatitis. 2022;86:357-378.
Diepgen TL, Elsner P, Schliemann S, et al. Guideline on the management of hand eczema ICD-10 Code: L20. L23. L24. L25. L30. J Dtsch Dermatol Ges. 2009;7(Suppl 3):S1-16.
Diepgen TL, Andersen KE, Chosidow O, et al. Guidelines for diagnosis, prevention and treatment of hand eczema. J Dtsch Dermatol Ges. 2015;13:e1-22.
Diepgen TL, Andersen KE, Brandao FM, et al. Hand eczema classification: a cross-sectional, multicentre study of the aetiology and morphology of hand eczema. Br J Dermatol. 2009;160:353-358.
Agner T, Aalto-Korte K, Andersen KE, et al. Classification of hand eczema. J Eur Acad Dermatol Venereol. 2015;29:2417-2422.
Agner T, Elsner P. Hand eczema: epidemiology, prognosis and prevention. J Eur Acad Dermatol Venereol. 2020;34(Suppl 1):4-12.
Menné T, Johansen JD, Sommerlund M, Veien NK. Hand eczema guidelines based on the Danish guidelines for the diagnosis and treatment of hand eczema. Contact Dermatitis. 2011;65:3-12.
Molin S, Diepgen TL, Ruzicka T, Prinz JC. Diagnosing chronic hand eczema by an algorithm: a tool for classification in clinical practice. Clin Exp Dermatol. 2011;36:595-601.
Thyssen JP, Johansen JD, Linneberg A, Menné T. The epidemiology of hand eczema in the general population - prevalence and main findings. Contact Dermatitis. 2010;62:75-87.
Yngveson M, Svensson A, Johannisson A, Isacsson A. Hand dermatosis in upper secondary school pupils: 2-year comparison and follow-up. Br J Dermatol. 2000;142:485-489.
Lerbaek A, Kyvik KO, Mortensen J, et al. Heritability of hand eczema is not explained by comorbidity with atopic dermatitis. J Invest Dermatol. 2007;127:1632-1640.
Meding B, Wrangsjö K, Järvholm B. Fifteen-year follow-up of hand eczema: predictive factors. J Invest Dermatol. 2005;124:893-897.
Reich A, Wilke A, Gediga G, et al. Health education decreases incidence of hand eczema in metal work apprentices: Results of a controlled intervention study. Contact Dermatitis. 2020;82:350-360.
Heede NG, Thyssen JP, Thuesen BH, et al. Predictive factors of self-reported hand eczema in adult Danes: a population-based cohort study with 5-year follow-up. Br J Dermatol. 2016;175:287-295.
Carøe TK, Ebbehøj N, Agner T. A survey of exposures related to recognized occupational contact dermatitis in Denmark in 2010. Contact Dermatitis. 2014;70:56-62.
Lund T, Petersen SB, Flachs EM, et al. Risk of work-related hand eczema in relation to wet work exposure. Scand J Work Environ Health. 2020;46:437-445.
Rycroft RJ, Smith WD. Low humidity occupational dermatoses. Contact Dermatitis. 1980;6:488-492.
Diepgen TL. Occupational skin-disease data in Europe. Int Arch Occup Environ Health. 2003;76:331-338.
Olesen CM, Agner T, Ebbehøj NE, Carøe TK. Factors influencing prognosis for occupational hand eczema: new trends. Br J Dermatol. 2019;181:1280-1286.
Sørensen JA, Fisker MH, Agner T, et al. Associations between lifestyle factors and hand eczema severity: are tobacco smoking, obesity and stress significantly linked to eczema severity? Contact Dermatitis. 2017;76:138-145.
Brans R, Skudlik C, Weisshaar E, et al. Association between tobacco smoking and prognosis of occupational hand eczema: a prospective cohort study. Br J Dermatol. 2014;171:1108-1115.
Cazzaniga S, Ballmer-Weber BK, Gräni N, et al. Chronic hand eczema: A prospective analysis of the Swiss CARPE registry focusing on factors associated with clinical and quality of life improvement. Contact Dermatitis. 2018;79:136-148.
Lukács J, Schliemann S, Elsner P. Association between smoking and hand dermatitis - a systematic review and meta-analysis. J Eur Acad Dermatol Venereol. 2015;29:1280-1284.
Sørensen JA, Clemmensen KK, Nixon RL, et al. Tobacco smoking and hand eczema - is there an association? Contact Dermatitis. 2015;73:326-335.
Zimmer KA, Armbrecht ES, Burkemper NM. The association of smoking with contact dermatitis and hand eczema - a review. Int J Dermatol. 2018;57:375-387.
Anveden Berglind I, Alderling M, Meding B. Life-style factors and hand eczema. Br J Dermatol. 2011;165:568-575.
Cazzaniga S, Ballmer-Weber BK, Gräni N, et al. Medical, psychological and socio-economic implications of chronic hand eczema: a cross-sectional study. J Eur Acad Dermatol Venereol. 2016;30:628-637.
Alfonso JH, Bauer A, Bensefa-Colas L, et al. Minimum standards on prevention, diagnosis and treatment of occupational and work-related skin diseases in Europe - position paper of the COST Action StanDerm (TD 1206). J Eur Acad Dermatol Venereol. 2017;31(Suppl 4):31-43.
Coenraads PJ. Hand eczema. N Engl J Med. 2012;367:1829-1837.
Molin S. [Pathogenesis of hand eczema]. Hautarzt. 2019;70:755-759.
Johansen JD, Hald M, Andersen BL, et al. Classification of hand eczema: clinical and aetiological types. Based on the guideline of the Danish Contact Dermatitis Group. Contact Dermatitis. 2011;65:13-21.
Politiek K, Loman L, Pas HH, et al. Hyperkeratotic hand eczema: Eczema or not? Contact Dermatitis. 2020;83:196-205.
van der Heiden J, Agner T, Rustemeyer T, Clemmensen KKB. Hyperkeratotic hand eczema compared to other subgroups of hand eczema - a retrospective study with a follow-up questionnaire. Contact Dermatitis. 2018;78:216-222.
Silverberg JI, Hou A, Warshaw EM, et al. Prevalence and trend of allergen sensitization in patients with nummular (discoid) eczema referred for patch testing: North American Contact Dermatitis Group data, 2001-2016. Contact Dermatitis. 2021;85:46-57.
Tauber M, Bérard E, Lourari S, et al. Latent class analysis categorizes chronic hand eczema patients according to skin barrier impairment. J Eur Acad Dermatol Venereol. 2020;34:1529-1535.
Mahler V, Nast A, Bauer A, et al. S3 guidelines: Epicutaneous patch testing with contact allergens and drugs - Short version, Part 2. J Dtsch Dermatol Ges. 2019;17:1187-1207.
Diepgen TL, Fartasch M, Hornstein OP. [Criteria of atopic skin diathesis]. Dermatol Beruf Umwelt. 1991;39:79-83.
Diepgen TL, Sauerbrei W, Fartasch M. Development and validation of diagnostic scores for atopic dermatitis incorporating criteria of data quality and practical usefulness. J Clin Epidemiol. 1996;49:1031-1038.
Berndt U, Hinnen U, Iliev D, Elsner P. Role of the atopy score and of single atopic features as risk factors for the development of hand eczema in trainee metal workers. Br J Dermatol. 1999;140:922-924.
Molin S, Ruzicka T, Herzinger T. Smoking is associated with combined allergic and irritant hand eczema, contact allergies and hyperhidrosis. J Eur Acad Dermatol Venereol. 2015;29:2483-2486.
Mahler V. Hand dermatitis - differential diagnoses, diagnostics, and treatment options. J Dtsch Dermatol Ges. 2016;14:7-26; quiz 27-8.
Agner T, Aalto-Korte K, Andersen KE, et al. Factors associated with combined hand and foot eczema. J Eur Acad Dermatol Venereol. 2017;31:828-832.
Antonov D, Schliemann S, Elsner P. Hand dermatitis: a review of clinical features, prevention and treatment. Am J Clin Dermatol. 2015;16:257-270.
Johansen JD, Aalto-Korte K, Agner T, et al. European Society of Contact Dermatitis guideline for diagnostic patch testing - recommendations on best practice. Contact Dermatitis. 2015;73:195-221.
Cronin E. Clinical patterns of hand eczema in women. Contact Dermatitis. 1985;13:153-161.
Mahler V, Nast A, Bauer A, et al. S3 guidelines: Epicutaneous patch testing with contact allergens and drugs - Short version, Part 1. J Dtsch Dermatol Ges. 2019;17:1076-1093.
Geier J, Dickel H, Bauer A. Epikutantestung mit patienteneigenem Material und Arbeitsstoffen. Allergo J. 2019;28:16-18.
Hannuksela M, Salo H. The repeated open application test (ROAT). Contact Dermatitis. 1986;14:221-227.
Johansen JD, Bruze M, Andersen KE, et al. The repeated open application test: suggestions for a scale of evaluation. Contact Dermatitis. 1998;39:95-96.
Dickel H, Kreft B, Kuss O, et al. Increased sensitivity of patch testing by standardized tape stripping beforehand: a multicenter diagnostic accuracy study. Contact Dermatitis. 2010;62:294-302.
Dickel H, Altmeyer P, Brasch J. “New” techniques for more sensitive patch testing? J Dtsch Dermatol Ges. 2011;9:889-896.
Dickel H, Geier J, Kreft B, et al. Comparing reliabilities of strip and conventional patch testing. Contact Dermatitis. 2017;76:342-349.
Dickel H, Mahler V. Leitliniengerechte Diagnostik der Kontaktallergie in der Praxis. Der Hautarzt. 2020;71:182-189.
Geier J, Bauer A, Becker D, et al. Empfehlungen der Arbeitsgruppe “Photopatchtest” der Deutschen Kontaktallergie-Gruppe (DKG) zur Durchführung des Photopatchtests. J Dtsch Dermatol Ges. 2018;16:1363-1364.
Johansen JD, Frosch PJ, Svedman C, et al. Hydroxyisohexyl 3-cyclohexene carboxaldehyde- known as Lyral: quantitative aspects and risk assessment of an important fragrance allergen. Contact Dermatitis. 2003;48:310-316.
Dickel H. [Exceptional occupational allergies due to food of animal origin]. Der Hautarzt. 2021;72:493-501.
Barbaud A. Mechanism and diagnosis of protein contact dermatitis. Curr Opin Allergy Clin Immunol. 2020;20:117-121.
Barbaud A, Poreaux C, Penven E, Waton J. Occupational protein contact dermatitis. Eur J Dermatol. 2015;25:527-534.
Bauer A, Schubert S, Geier J, Mahler V. [Type IV contact allergies in the food processing industry: an update]. Hautarzt. 2018;69:443-448.
Hjorth N, Roed-Petersen J. Occupational protein contact dermatitis in food handlers. Contact Dermatitis. 1976;2:28-42.
Lukács J, Schliemann S, Elsner P. Occupational contact urticaria caused by food - a systematic clinical review. Contact Dermatitis. 2016;75:195-204.
Pesonen M, Koskela K, Aalto-Korte K. Contact urticaria and protein contact dermatitis in the Finnish Register of Occupational Diseases in a period of 12 years. Contact Dermatitis. 2020;83:1-7.
Ruëff F, Bergmann K-C, Brockow K, et al. Hauttests zur Diagnostik von allergischen Soforttypreaktionen. Allergo J. 2010;19:402-415.
Bousquet J, Heinzerling L, Bachert C, et al. Practical guide to skin prick tests in allergy to aeroallergens. (Position paper). Allergy. 2012;67:18-24.
Heinzerling L, Mari A, Bergmann K-C, et al. The skin prick test - European standards. Clin Transl Allergy. 2013;3:3.
Ansotegui IJ, Melioli G, Canonica GW, et al. IgE allergy diagnostics and other relevant tests in allergy, a World Allergy Organization position paper. World Allergy Organ J. 2020;13:100080.
Renz H, Biedermann T, Bufe A, et al. Leitlinien-Update 061/017 In-vitro-Allergiediagnostik1, 2 /In-vitro allergy diagnostics Deutsche Gesellschaft für Allergologie und Klinische Immunologie (DGAKI), Ärzteverband deutscher Allergologen (ÄDA), Gesellschaft für pädiatrische Allergologie (GPA), Deutsche Dermatologische Gesellschaft (DDG). Lab Medizin. 2010;34:177-195.
Haslund P, Bangsgaard N, Jarlov JO, et al. Staphylococcus aureus and hand eczema severity. Br J Dermatol. 2009;161:772-777.
Wiegand C, Bauer A, Brasch J, et al. Are the classic diagnostic methods in mycology still state of the art? J Dtsch Dermatol Ges. 2016;14:490-494.
Fatahzadeh M, Schwartz RA. Human herpes simplex virus infections: epidemiology, pathogenesis, symptomatology, diagnosis, and management. J Am Acad Dermatol. 2007;57:737-763.
Quaranta M, Knapp B, Garzorz N, et al. Intraindividual genome expression analysis reveals a specific molecular signature of psoriasis and eczema. Sci Transl Med. 2014;6:244ra90.
Garzorz-Stark N, Krause L, Lauffer F, et al. A novel molecular disease classifier for psoriasis and eczema. Exp Dermatol. 2016;25:767-774.
Sølberg JBK, Quaade AS, Jacobsen SB, et al. The transcriptome of hand eczema assessed by tape stripping. Contact Dermatitis. 2022;86:71-79.
Sølberg JBK, Quaade AS, Drici L, et al. The proteome of hand eczema assessed by tape stripping. J Invest Dermatol. 2023:S0022-202X(23)00071-4 [Epub ahead of print].
John SM, Bartel G, Brehler R, et al. Negativliste: Hautirritabilitäts- und Hautfunktionsdiagnostik zur Erfassung und Bewertung irritativer Hautschäden. ABD-Arbeitsgruppe “Erfassung und Bewertung irritativer Hautschäden”. Dermatol Beruf Umwelt. 2006;54:108-111.
Friis UF, Menné T, Flyvholm MA, et al. Occupational allergic contact dermatitis diagnosed by a systematic stepwise exposure assessment of allergens in the work environment. Contact Dermatitis. 2013;69:153-163.
Diepgen TL. Occupational skin diseases. J Dtsch Dermatol Ges. 2012;10:297-313;quiz 314-315.
Brans R, Skudlik C. [Prevention of hand eczema]. Hautarzt. 2019;70:797-803.
Berufsgenossenschaft für Gesundheitsdienst und Wohlfahrtspflege. Technische Regeln für Gefahrstoffe: Gefährdung durch Hautkontakt - Ermittlung, Beurteilung, Maßnahmen (TGRS 401) - Fassung v. 18.11.2022. 23.02.2023 Available from: https://www.bgw-online.de/bgw-online-de/service/medien-arbeitshilfen/medien-center/gefaehrdung-durch-hautkontakt-ermittlung-beurteilung-13784 [Last Accessed February 23, 2023].
Brandenburg S, Woltjen M. Präventonsbegriffe in der Berufsdermatologie und der gesetzlichen Unfallversicherung. Dermatol Beruf Umwelt. 2018;66:126-134.
Alinaghi F, Zachariae C, Thyssen JP, Johansen JD. Temporal changes in chromium allergy in Denmark between 2002 and 2017. Contact Dermatitis. 2019;80:156-161.
Stocks SJ, McNamee R, Turner S, et al. Has European Union legislation to reduce exposure to chromate in cement been effective in reducing the incidence of allergic contact dermatitis attributed to chromate in the UK? Occup Environ Med. 2012;69:150-152.
Ahlström MG, Thyssen JP, Menné T, Johansen JD. Prevalence of nickel allergy in Europe following the EU Nickel Directive - a review. Contact Dermatitis. 2017;77:193-200.
Schnuch A, Schwitulla J. Decrease in nickel allergy in women after the second EU nickel directive. Contact Dermatitis. 2013;69:253-256.
Uter W, Aalto-Korte K, Agner T, et al. The epidemic of methylisothiazolinone contact allergy in Europe: follow-up on changing exposures. J Eur Acad Dermatol Venereol. 2020;34:333-339.
Carøe TK, Ebbehøj NE, Bonde JPE et al. Hand eczema and wet work: dose-response relationship and effect of leaving the profession. Contact Dermatitis. 2018;78:341-347.
Held E, Wolff C, Gyntelberg F, Agner T. Prevention of work-related skin problems in student auxiliary nurses: an intervention study. Contact Dermatitis. 2001;44:297-303.
Uter W, Pfahlberg A, Gefeller O, Schwanitz HJ. Hand dermatitis in a prospectively-followed cohort of hairdressing apprentices: final results of the POSH study. Prevention of occupational skin disease in hairdressers. Contact Dermatitis. 1999;41:280-286.
Agner T, Held E. Skin protection programmes. Contact Dermatitis. 2002;47:253-256.
Geens T, Aerts E, Borguet M, et al. Exposure of hairdressers to aromatic diamines: an interventional study confirming the protective effect of adequate glove use. Occup Environ Med. 2016;73:221-228.
Kwon S, Campbell LS, Zirwas MJ. Role of protective gloves in the causation and treatment of occupational irritant contact dermatitis. J Am Acad Dermatol. 2006;55:891-896.
Havmose M, Thyssen JP, Zachariae C, Johansen JD. Use of protective gloves by hairdressers: A review of efficacy and potential adverse effects. Contact Dermatitis. 2020;83:75-82.
Ramsing DW, Agner T. Effect of glove occlusion on human skin. (I). short-term experimental exposure. Contact Dermatitis. 1996;34:1-5.
Tiedemann D, Clausen ML, John SM, et al. Effect of glove occlusion on the skin barrier. Contact Dermatitis. 2016;74:2-10.
Agner T, Serup J. Seasonal variation of skin resistance to irritants. Br J Dermatol. 1989;121:323-328.
Hamnerius N, Svedman C, Bergendorff O, et al. Wet work exposure and hand eczema among healthcare workers: a cross-sectional study. Br J Dermatol. 2018;178:452-461.
Kampf G, Löffler H. Prevention of irritant contact dermatitis among health care workers by using evidence-based hand hygiene practices: a review. Ind Health. 2007;45:645-652.
Ramsing DW, Agner T. Effect of glove occlusion on human skin (II). Long-term experimental exposure. Contact Dermatitis. 1996;34:258-262.
Visser MJ, Verberk MM, van Dijk FJ, et al. Wet work and hand eczema in apprentice nurses; part I of a prospective cohort study. Contact Dermatitis. 2014;70:44-55.
Berardesca E, Vignoli GP, Distante F, et al. Effects of water temperature on surfactant-induced skin irritation. Contact Dermatitis. 1995;32:83-87.
Mahler V, Aalto-Korte K, Alfonso JH, et al. Occupational skin diseases: actual state analysis of patient management pathways in 28 European countries. J Eur Acad Dermatol Venereol. 2017;31(Suppl 4):12-30.
Löffler H, Kampf G, Schmermund D, Maibach HI. How irritant is alcohol? Br J Dermatol. 2007;157:74-81.
Yokota M, Maibach HI. Moisturizer effect on irritant dermatitis: an overview. Contact Dermatitis. 2006;55:65-72.
Fartasch M, Diepgen TL, Drexler H, et al. S1 guideline on occupational skin products: protective creams, skin cleansers, skin care products (ICD 10: L23, L24) - short version. J Dtsch Dermatol Ges. 2015;13:594-606.
Bauer A, Rönsch H, Elsner P, et al. Interventions for preventing occupational irritant hand dermatitis. Cochrane Database Syst Rev. 2018;4:Cd004414.
Wigger-Alberti W, Maraffio B, Wernli M, Elsner P. Self-application of a protective cream. Pitfalls of occupational skin protection. Arch Dermatol. 1997;133:861-864.
Williams C, Wilkinson SM, McShane P, et al. A double-blind, randomized study to assess the effectiveness of different moisturizers in preventing dermatitis induced by hand washing to simulate healthcare use. Br J Dermatol. 2010;162:1088-1092.
Schliemann S, Petri M, Elsner P. Preventing irritant contact dermatitis with protective creams: influence of the application dose. Contact Dermatitis. 2014;70:19-26.
Bruusgaard-Mouritsen MA, Johansen JD, Zachariae C, et al. Natural ingredients in cosmetic products-A suggestion for a screening series for skin allergy. Contact Dermatitis. 2020;83:251-270.
Dinkloh A, Worm M, Geier J, et al. Contact sensitization in patients with suspected cosmetic intolerance: results of the IVDK 2006-2011. J Eur Acad Dermatol Venereol. 2015;29:1071-1081.
Nguyen HL, Yiannias JA. Contact dermatitis to medications and skin products. Clin Rev Allergy Immunol. 2019;56:41-59.
Uter W, Geier J, Lessmann H, Schnuch A. Inhaltsstoffe von Hautschutz- und -pflegemitteln aus allergologischer Sicht. Analyse von IVDK-Daten und Literaturübersicht. Dermatol Beruf Umwelt. 2005;53:172-182.
Wetter DA, Yiannias JA, Prakash AV, et al. Results of patch testing to personal care product allergens in a standard series and a supplemental cosmetic series: an analysis of 945 patients from the Mayo Clinic Contact Dermatitis Group, 2000-2007. J Am Acad Dermatol. 2010;63:789-798.
Christoffers WA, Coenraads PJ, Svensson Å, et al. Interventions for hand eczema. Cochrane Database Syst Rev. 2019;4:Cd004055.
Held E, Skoet R, Johansen JD, Agner T. The hand, eczema severity index (HECSI): a scoring system for clinical assessment of hand, eczema. A study of inter- and intraobserver reliability. Br J Dermatol. 2005;152:302-307.
Oosterhaven JAF, Schuttelaar MLA. Responsiveness and interpretability of the Hand Eczema Severity Index. Br J Dermatol. 2020;182:932-939.
Yüksel YT, Agner T, Ofenloch R. New evidence on the minimal important change (MIC) for the Hand Eczema Severity Index (HECSI). Contact Dermatitis. 2021 [Epub ahead of print].
Coenraads PJ, Van Der Walle H, Thestrup-Pedersen K, et al. Construction and validation of a photographic guide for assessing severity of chronic hand dermatitis. Br J Dermatol. 2005;152:296-301.
ClinicalTrials.gov. Identifier NCT00556855. A 4-week randomized, double-blind, placebocontrolled, right-left comparison study with E-DO® in chronic hand dermatitis [Comparison study with E-DO in chronic hand dermatitis] [Internet]. 2020 Sep 18, Available from: https://clinicaltrials.gov/ct2/show/NCT00556855 [Last accessed September 18, 2020].
Kucharekova M, Van De Kerkhof PC, Van Der Valk PG. A randomized comparison of an emollient containing skin-related lipids with a petrolatum-based emollient as adjunct in the treatment of chronic hand dermatitis. Contact Dermatitis. 2003;48:293-299.
Berndt U, Wigger-Alberti W, Gabard B, Elsner P. Efficacy of a barrier cream and its vehicle as protective measures against occupational irritant contact dermatitis. Contact Dermatitis. 2000;42:77-80.
Lodén M, Wirén K, Smerud K, et al. Treatment with a barrier-strengthening moisturizer prevents relapse of hand-eczema. An open, randomized, prospective, parallel group study. Acta Derm Venereol. 2010;90:602-606.
McCormick RD, Buchman TL, Maki DG. Double-blind, randomized trial of scheduled use of a novel barrier cream and an oil-containing lotion for protecting the hands of health care workers. Am J Infect Control. 2000;28:302-310.
Lindh JD, Bradley M. Clinical effectiveness of moisturizers in atopic dermatitis and related disorders: a systematic review. Am J Clin Dermatol. 2015;16:341-359.
van Zuuren EJ, Fedorowicz Z, Christensen R, et al. Emollients and moisturisers for eczema. Cochrane Database Syst Rev. 2017;2:Cd012119.
Kircik LH, Eastman WJ, Gwazdauskas J. A randomized, double-blind phase 4 study of the efficacy and safety of ethanol-free clobetasol propionate foam, 0.05%, vs vehicle foam in the treatment of chronic hand dermatitis. J Drugs Dermatol. 2013;12:328-334.
Veien NK, Olholm Larsen P, Thestrup-Pedersen K, Schou G. Long-term, intermittent treatment of chronic hand eczema with mometasone furoate. Br J Dermatol. 1999;140:882-886.
Del Rosso JQ, Cash K. Topical corticosteroid application and the structural and functional integrity of the epidermal barrier. J Clin Aesthet Dermatol. 2013;6:20-27.
Kao JS, Fluhr JW, Man MQ, et al. Short-term glucocorticoid treatment compromises both permeability barrier homeostasis and stratum corneum integrity: inhibition of epidermal lipid synthesis accounts for functional abnormalities. J Invest Dermatol. 2003;120:456-464.
Schoepe S, Schäcke H, May E, Asadullah K. Glucocorticoid therapy-induced skin atrophy. Exp Dermatol. 2006;15:406-420.
Luger T, Loske KD, Elsner P, et al. [Topical skin therapy with glucocorticoids-therapeutic index]. J Dtsch Dermatol Ges. 2004;2:629-634.
Spada F, Barnes TM, Greive KA. Comparative safety and efficacy of topical mometasone furoate with other topical corticosteroids. Australas J Dermatol. 2018;59:e168-e174.
Lodén M, Wirén K, Smerud KT, et al. The effect of a corticosteroid cream and a barrier-strengthening moisturizer in hand eczema. A double-blind, randomized, prospective, parallel group clinical trial. J Eur Acad Dermatol Venereol. 2012;26:597-601.
Green C, Colquitt JL, Kirby J, Davidson P. Topical corticosteroids for atopic eczema: clinical and cost effectiveness of once-daily vs. more frequent use. Br J Dermatol. 2005;152:130-141.
Hoare C, Li Wan Po A, Williams H. Systematic review of treatments for atopic eczema. Health Technol Assess. 2000;4:1-191.
Lagos BR, Maibach HI. Frequency of application of topical corticosteroids: an overview. Br J Dermatol. 1998;139:763-766.
Cheon DU, Kim JE, Ko JY, Ro YS. Efficacy of alitretinoin depending on the concomitant use of topical corticosteroids in chronic hand eczema patients. J Dermatol. 2019;46:998-1005.
Schnopp C, Remling R, Möhrenschlager M, et al. Topical tacrolimus (FK506) and mometasone furoate in treatment of dyshidrotic palmar eczema: a randomized, observer-blinded trial. J Am Acad Dermatol. 2002;46:73-77.
Baeck M, Goossens A. Immediate and delayed allergic hypersensitivity to corticosteroids: practical guidelines. Contact Dermatitis. 2012;66:38-45.
Li AW, Yin ES, Antaya RJ. Topical corticosteroid phobia in atopic dermatitis: A systematic review. JAMA Dermatol. 2017;153:1036-1042.
Lambrechts L, Gilissen L, Morren MA. Topical corticosteroid phobia among healthcare professionals using the TOPICOP Score. Acta Derm Venereol. 2019;99:1004-1008.
Pacor ML, Di Lorenzo G, Martinelli N, et al. Tacrolimus ointment in nickel sulphate-induced steroid-resistant allergic contact dermatitis. Allergy Asthma Proc. 2006;27:527-531.
Rzany B, Bechara FG, Feise K, et al. Aktualisierung der S1-Leitlinie zur Definition und Therapie der primären Hyperhidrose. J Dtsch Dermatol Ges. 2018;16:945-953.
Brass D, Fouweather T, Stocken DD, et al. An observer-blinded randomized controlled pilot trial comparing localized immersion psoralen-ultraviolet A with localized narrowband ultraviolet B for the treatment of palmar hand eczema. Br J Dermatol. 2018;179:63-71.
Tzaneva S, Kittler H, Thallinger C, et al. Oral vs. bath PUVA using 8-methoxypsoralen for chronic palmoplantar eczema. Photodermatol Photoimmunol Photomed. 2009;25:101-105.
van Coevorden AM, Kamphof WG, van Sonderen E, et al. Comparison of oral psoralen-UV-A with a portable tanning unit at home vs hospital-administered bath psoralen-UV-A in patients with chronic hand eczema: an open-label randomized controlled trial of efficacy. Arch Dermatol. 2004;140:1463-1466.
Adams S, Bayerl C. Mittel-Dosis-UVA-1- und lokale PUVA-Therapie beim dyshidrosiformen Handekzem - eine prospektive randomisierte Studie. Aktuelle Derm. 2007;33:142-145.
Said N, Lim K, Chong W, CTS T. A comparative study of UVA-1 phototherapy versus betamethasone valerate 0.1% cream for chronic vesicular Handekzem. J Am Acad Dermatol. 64:AB139.
Nijsten TE, Stern RS. The increased risk of skin cancer is persistent after discontinuation of psoralen + ultraviolet A: a cohort study. J Invest Dermatol. 2003;121:252-258.
Cartwright PH, Rowell NR. Comparison of Grenz rays versus placebo in the treatment of chronic hand eczema. Br J Dermatol. 1987;117:73-76.
Fairris GM, Jones DH, Mack DP, Rowell NR. Conventional superficial X-ray versus Grenz ray therapy in the treatment of constitutional eczema of the hands. Br J Dermatol. 1985;112:339-341.
Fairris GM, Mack DP, Rowell NR. Superficial X-ray therapy in the treatment of constitutional eczema of the hands. Br J Dermatol. 1984;111:445-449.
King CM, Chalmers RJ. A double-blind study of superficial radiotherapy in chronic palmar eczema. Br J Dermatol. 1984;111:451-454.
Lindelöf B, Wrangsjö K, Lidén S. A double-blind study of Grenz ray therapy in chronic eczema of the hands. Br J Dermatol. 1987;117:77-80.
Sheehan-Dare RA, Goodfield MJ, Rowell NR. Topical psoralen photochemotherapy (PUVA) and superficial radiotherapy in the treatment of chronic hand eczema. Br J Dermatol. 1989;121:65-69.
Ruzicka T, Lynde CW, Jemec GB, et al. Efficacy and safety of oral alitretinoin (9-cis retinoic acid) in patients with severe chronic hand eczema refractory to topical corticosteroids: results of a randomized, double-blind, placebo-controlled, multicentre trial. Br J Dermatol. 2008;158:808-817.
European Medicines Agency. SmPC text alitretinoin. 2020 Sep 24. Available from: https://www.medicines.org.uk/emc/product/10466/smpc [Last accessed September 24, 2020].
Bissonnette R, Worm M, Gerlach B, et al. Successful retreatment with alitretinoin in patients with relapsed chronic hand eczema. Br J Dermatol. 2010;162:420-426.
Lynde C, Cambazard F, Ruzicka T, et al. Extended treatment with oral alitretinoin for patients with chronic hand eczema not fully responding to initial treatment. Clin Exp Dermatol. 2012;37:712-717.
Thestrup-Pedersen K, Andersen KE, Menné T, Veien NK. Treatment of hyperkeratotic dermatitis of the palms (eczema keratoticum) with oral acitretin. A single-blind placebo-controlled study. Acta Derm Venereol. 2001;81:353-355.
Granlund H, Erkko P, Eriksson E, Reitamo S. Comparison of cyclosporine and topical betamethasone-17,21-dipropionate in the treatment of severe chronic hand eczema. Acta Derm Venereol. 1996;76:371-376.
Granlund H, Erkko P, Reitamo S. Long-term follow-up of eczema patients treated with cyclosporine. Acta Derm Venereol. 1998;78:40-43.
Jang YJ, Yoon JH, Park EJ, et al. Efficacy and safety of treatment with oral alitretinoin and oral cyclosporine for chronic hand eczema: a retrospective review of 118 cases. Acta Derm Venereol. 2020;100:adv00043.
Agarwal US, Besarwal RK. Topical clobetasol propionate 0.05% cream alone and in combination with azathioprine in patients with chronic hand eczema: an observer blinded randomized comparative trial. Indian J Dermatol Venereol Leprol. 2013;79:101-103.
O'Shea PM, Lugo-Somolinos A. Methotrexate versus acitretin in the treatment of chronic hand dermatitis. J Drugs Dermatol. 2015;14:1389-1391.
Politiek K, van der Schaft J, Christoffers WA, et al. Drug survival of methotrexate treatment in hand eczema patients: results from a retrospective daily practice study. J Eur Acad Dermatol Venereol. 2016;30:1405-1407.
Voorberg AN, Romeijn GLE, de Bruin-Weller MS, Schuttelaar MLA. The long-term effect of dupilumab on chronic hand eczema in patients with moderate to severe atopic dermatitis-52 week results from the Dutch BioDay Registry. Contact Dermatitis. 2022;87:185-191.
Oosterhaven JAF, Voorberg AN, Romeijn GLE, et al. Effect of dupilumab on hand eczema in patients with atopic dermatitis: An observational study. J Dermatol. 2019;46:680-685.
Waldman RA, DeWane ME, Sloan B, et al. Dupilumab for the treatment of dyshidrotic eczema in 15 consecutive patients. J Am Acad Dermatol. 2020;82:1251-1252.
Halling AS, Zachariae C, Thyssen JP. Severe treatment-resistant acute and recurrent vesicular chronic hand eczema successfully treated with dupilumab. Contact Dermatitis. 2020;83:37-38.
Loman L, Diercks GFH, Schuttelaar MLA. Three cases of non-atopic hyperkeratotic hand eczema treated with dupilumab. Contact Dermatitis. 2021;84:124-127.
Werfel T, et al. S2k-Leitlinie Neurodermitis (AWMF-Registernummer 013-027). Available from: https://register.awmf.org/de/leitlinien/detail/013-027 [Last accessed February 23, 2023].
Worm M, Bauer A, Elsner P, et al. Efficacy and safety of topical delgocitinib in patients with chronic hand eczema: data from a randomized, double-blind, vehicle-controlled phase IIa study. Br J Dermatol. 2020;182:1103-1110.
Worm M, Thyssen JP, Schliemann S, et al. The pan-JAK inhibitor delgocitinib in a cream formulation demonstrates dose response in chronic hand eczema in a 16-week randomized phase IIb trial. Br J Dermatol. 2022;187:42-51.